PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Oncology, Geneva University Hospitals, University of Geneva, Swiss Cancer Center Leman, Switzerland. Electronic address: alfredo.addeo@hcuge.ch.\', \'Mays Cancer Center at UT Health San Antonio MD Anderson, San Antonio, TX, USA.\', \'Department of Oncology, Geneva University Hospitals, University of Geneva, Swiss Cancer Center Leman, Switzerland.\', \'Division of Infectious Diseases, Department of Medicine, Joe R. and Teresa Lozano Long School of Medicine, UT Health San Antonio, San Antonio, TX, USA.\', \'Department of Oncology, Geneva University Hospitals, University of Geneva, Swiss Cancer Center Leman, Switzerland; Center of Translational Research in Onco-Hematology, Faculty of Medicine, University of Geneva, Swiss Cancer Center Leman, Geneva, Switzerland.\', \'Mays Cancer Center at UT Health San Antonio MD Anderson, San Antonio, TX, USA. Electronic address: shahdp@uthscsa.edu.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • S1535-6108(21)00330-510.1016/j.ccell.2021.06.009
?:hasPublicationType
?:journal
  • Cancer cell
is ?:pmid of
?:pmid
?:pmid
  • 34214473
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 12.7
?:rankingScore_hIndex
  • 284
?:title
  • Immunogenicity of SARS-CoV-2 messenger RNA vaccines in patients with cancer.
?:type
?:year
  • 2021

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/34214473>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/34214473>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all